<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurosurg Case Lessons</journal-id><journal-id journal-id-type="iso-abbrev">J Neurosurg Case Lessons</journal-id><journal-id journal-id-type="publisher-id">J Neurosurg Case Lessons</journal-id><journal-title-group><journal-title>Journal of Neurosurgery: Case Lessons</journal-title></journal-title-group><issn pub-type="epub">2694-1902</issn><publisher><publisher-name>American Association of Neurological Surgeons</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9435553</article-id><article-id pub-id-type="doi">10.3171/CASE21170</article-id><article-id pub-id-type="publisher-id">CASE21170</article-id><article-categories><subj-group subj-group-type="subjects"><compound-subject><compound-subject-part content-type="code">Infection</compound-subject-part><compound-subject-part content-type="label">Infection</compound-subject-part></compound-subject></subj-group><subj-group subj-group-type="heading"><subject>Case Lesson</subject></subj-group></article-categories><title-group><article-title>Presentation, diagnosis, and treatment of a cerebellar tuberculoma: illustrative case</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Capone</surname><given-names>Stephen</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">1,</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Emechebe</surname><given-names>Dokpe</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>St. Clair</surname><given-names>Eric G.</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Sadr</surname><given-names>Ali</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Feinberg</surname><given-names>Michelle</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><aff id="aff1"><label>1</label>St. George&#x02019;s University School of Medicine, Grenada, West Indies</aff><aff id="aff2"><label>2</label>Department of Neurosurgery, Kings County Hospital Center, Brooklyn, New York; and </aff><aff id="aff3"><label>3</label>Department of Pathology, SUNY Downstate Medical Center, Brooklyn, New York</aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence</bold> Stephen Capone: St. George&#x02019;s University School of Medicine, Grenada, West Indies. <email>stephencaponemd@gmail.com</email>.</corresp><fn id="fn1"><p><bold>INCLUDE WHEN CITING</bold> Published November 1, 2021; DOI: 10.3171/CASE21170.</p></fn><fn fn-type="COI-statement" id="fn2"><p><bold>Disclosures</bold> The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.</p></fn></author-notes><pub-date pub-type="collection"><day>1</day><month>11</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>1</day><month>11</month><year>2021</year></pub-date><volume>2</volume><issue>18</issue><elocation-id>CASE21170</elocation-id><history>
<date date-type="received"><day>28</day><month>6</month><year>2021</year></date>
<date date-type="accepted"><day>12</day><month>7</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The authors</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>CC BY-NC-ND 4.0 (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><self-uri content-type="pdf" xlink:href="CASE21170.pdf"/><abstract><sec><title>BACKGROUND</title><p>Central nervous system (CNS) tuberculomas are a feared complication of tuberculosis (TB) infection. These lesions can present in varying manners and are associated with significant morbidity and mortality. Prompt diagnosis and treatment of the lesion and the underlying infection are critical in the care of these patients. The authors presented a case of a 45-year-old Yemeni immigrant presenting with a 3-month history of severe right temporo-occipital headaches with photophobia and night sweats. Imaging showed a rim-enhancing lesion in the right cerebellar hemisphere.</p></sec><sec><title>OBSERVATIONS</title><p>Laboratory tests were unremarkable and within normal limits. QuantiFERON testing was negative, ruling out latent TB infection. The patient received a suboccipital craniotomy, and resection of the cerebellar lesion showed caseating granuloma formation, which was positive for acid-fast bacilli and Fite stain.</p></sec><sec><title>LESSONS</title><p>CNS tuberculomas are an important differential to consider in patients with a history of primary TB, regardless of active disease or immunocompetent status. Resection of these lesions remains a viable treatment option that is safe and effective.</p></sec></abstract><kwd-group><kwd>cerebellar</kwd><kwd>tuberculoma</kwd><kwd>infection</kwd><kwd>granuloma</kwd><kwd>tuberculosis</kwd></kwd-group><kwd-group kwd-group-type="abbrev"><title>
ABBREVIATIONS
</title><kwd>AFB = acid-fast bacilli</kwd><kwd>CNS = central nervous system</kwd><kwd>CSF = cerebrospinal fluid</kwd><kwd>CT = computed tomography</kwd><kwd>MRI = magnetic resonance imaging</kwd><kwd>NAAT = nucleic acid-based amplification technique</kwd><kwd>RIPE = isoniazid, rifampin, ethambutol, and pyrazinamide</kwd><kwd>TB = tuberculosis</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><ref-count count="20"/><page-count count="4"/></counts></article-meta></front><body><p>Although the incidence of tuberculosis (TB) remains low in developed countries, one of the feared complications is central nervous system (CNS) infection. CNS TB can present as tuberculous meningitis, osteomyelitis of the spine, or a distinct mass referred to as a tuberculoma,<sup><xref rid="b1" ref-type="bibr">1</xref></sup> all of which contain active <italic toggle="yes">Mycobacterium tuberculosis</italic> and are highly contagious. These discrete tuberculoma lesions can present in unique manners, masquerading as hematomas,<sup><xref rid="b2" ref-type="bibr">2</xref></sup> intracranial tumors,<sup><xref rid="b3" ref-type="bibr">3</xref>,<xref rid="b4" ref-type="bibr">4</xref></sup> or multiple CNS lesions,<sup><xref rid="b5" ref-type="bibr">5</xref></sup> and they are commonly found in children, immunosuppressed patients, or patients with active TB.<sup><xref rid="b6" ref-type="bibr">6&#x02013;8</xref></sup> On computed tomography (CT) and magnetic resonance imaging (MRI), tuberculomas typically appear as ring-enhancing or hyperdense lesions with associated edema,<sup><xref rid="b9" ref-type="bibr">9</xref>,<xref rid="b10" ref-type="bibr">10</xref></sup> although distinctive imaging characteristics are not well established. Because of this, intracranial tuberculomas can be misdiagnosed as numerous other intracranial pathologies, particularly when there is a low suspicion of active TB or prior exposure.</p><p>The case rate of TB has decreased progressively over years, with fewer than 10,000 cases annually in the United States.<sup><xref rid="b11" ref-type="bibr">11</xref>,<xref rid="b12" ref-type="bibr">12</xref></sup> Despite the declining rate in the United States, the disease burden of TB infection remains a concern across World Health Organization member states.<sup><xref rid="b12" ref-type="bibr">12</xref></sup> Although rare, CNS TB accounts for approximately 1%&#x02013;2% of all TB cases worldwide and can have significant morbidity and mortality.<sup><xref rid="b10" ref-type="bibr">10</xref></sup> Here we present a rare case of a CNS tuberculoma, interestingly presenting in an immunocompetent patient without active pulmonary disease or latent infection.</p><sec id="s2"><title>Illustrative Case</title><sec><title>Presentation</title><p>A 45-year-old male Yemeni immigrant presented to the Kings County Hospital Center emergency department in Brooklyn, New York, with a 3-month history of severe right temporo-occipital headaches with photophobia and night sweats. The patient denied fevers, cough, chest pain, shortness of breath, and weight loss. On presentation, the patient was neurologically intact and afebrile, and laboratory studies were unremarkable (<xref rid="t1" ref-type="table">Table 1</xref>). A head CT scan showed a partially calcified 2.5 &#x000d7; 2.0 cm extra-axial right cerebellar mass with adjacent vasogenic edema (<xref rid="f1" ref-type="fig">Fig. 1</xref>). The differential included a calcified meningioma versus an atypical infectious process. MRI showed a heterogenous peripherally enhancing lesion in the posterior right cerebellar hemisphere with irregular margins and surrounding presumed vasogenic edema on both T1-weighted postcontrast and T2-weighted sequences (<xref rid="f2" ref-type="fig">Fig. 2</xref>). There was no evidence of elevated cerebral blood volume on perfusion imaging but mild distortion of the fourth ventricle due to mass effect. Differential diagnosis included atypical infectious process, including parasitic or granulomatous infection, versus a brain neoplasm. At this stage, further examination of the mass was warranted. Because infection could not be ruled out, the patient received additional testing and tested negative for toxoplasma, cysticercosis, <italic toggle="yes">Aspergillus</italic>, and the presence of (1,3)-beta-D-glucans but he tested positive for schistosoma antibodies. QuantiFERON testing on hospital day 4 showed negative results, ruling out latent TB infection.<sup><xref rid="b13" ref-type="bibr">13</xref>,<xref rid="b14" ref-type="bibr">14</xref></sup> CT of the chest/abdomen/pelvis showed no evidence of intrathoracic or abdominal metastasis but showed calcified mediastinal, left hilar, and mesenteric lymph nodes suggestive of prior granulomatous disease. Because of the risk associated with lumbar punctures with a posterior fossa mass, cerebrospinal fluid (CSF) analysis was not able to be performed. Treatment options were discussed with the patient, and he consented to resection of the mass.</p><fig position="float" id="f1"><label>FIG. 1.</label><caption><p>Noncontrast head CT of the patient showing the brain (<bold>left</bold>) and bone (<bold>right</bold>) windows demonstrates a solitary calcified mass in the right cerebellar hemisphere with surrounding vasogenic edema.</p></caption><graphic xlink:href="CASE21170f1" position="float"/></fig><fig position="float" id="f2"><label>FIG. 2.</label><caption><p>Brain MRI performed preoperatively. T1 postcontrast imaging (<bold>left</bold>) demonstrates a heterogenous peripherally enhancing lesion in the posterior right cerebellar hemisphere with irregular margins and surrounding presumed vasogenic edema. T2 imaging (<bold>right</bold>) shows an isointense to mildly hyperintense signal with avid irregular enhancement. These findings are consistent with the posterior fossa calcified mass demonstrated on CT.</p></caption><graphic xlink:href="CASE21170f2" position="float"/></fig><table-wrap position="float" id="t1"><label>TABLE 1.</label><caption><p>Laboratory results for blood tests on admission</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col/><col/></colgroup><thead><tr><th align="center">Test</th><th align="center">Result</th></tr></thead><tbody><tr><td colspan="2" align="left">Complete blood count<hr/></td></tr><tr><td align="left">WBC<hr/></td><td align="center">7.49 k/uL<hr/></td></tr><tr><td align="left">HGB<hr/></td><td align="center">13.9 g/dL<hr/></td></tr><tr><td align="left">HCT<hr/></td><td align="center">42.7%<hr/></td></tr><tr><td align="left">PLT<hr/></td><td align="center">177 &#x000d7; 10<sup>9</sup>/L<hr/></td></tr><tr><td align="left">Neutrophil<hr/></td><td align="center">57.9%<hr/></td></tr><tr><td align="left">Lymphocyte<hr/></td><td align="center">24.2%<hr/></td></tr><tr><td align="left">Monocyte<hr/></td><td align="center">5.7%<hr/></td></tr><tr><td align="left">Eosinophil<hr/></td><td align="center">11.6% (<inline-formula><mml:math id="i1" display="inline"><mml:mo>&#x02191;</mml:mo></mml:math></inline-formula>)<hr/></td></tr><tr><td align="left">Basophil<hr/></td><td align="center">0.5%<hr/></td></tr><tr><td colspan="2" align="left">Basic metabolic panel<hr/></td></tr><tr><td align="left">Sodium<hr/></td><td align="center">140 mEq/L<hr/></td></tr><tr><td align="left">Potassium<hr/></td><td align="center">4.1 mEq/L<hr/></td></tr><tr><td align="left">Chloride<hr/></td><td align="center">104 mEq/L<hr/></td></tr><tr><td align="left">CO<sub>2</sub><hr/></td><td align="center">26 mEq/L<hr/></td></tr><tr><td align="left">Glucose<hr/></td><td align="center">102 mg/dL<hr/></td></tr><tr><td align="left">BUN<hr/></td><td align="center">20.0 mg/dL<hr/></td></tr><tr><td align="left">Creatinine<hr/></td><td align="center">0.92 mg/dL<hr/></td></tr><tr><td align="left">Calcium<hr/></td><td align="center">9.7 mg/dL<hr/></td></tr><tr><td align="left">Magnesium<hr/></td><td align="center">2.06 mEq/L<hr/></td></tr><tr><td align="left">Phosphorus<hr/></td><td align="center">3.5 mg/dL<hr/></td></tr><tr><td colspan="2" align="left">Hepatic function<hr/></td></tr><tr><td align="left">Total bilirubin<hr/></td><td align="center">0.3 mg/dL<hr/></td></tr><tr><td align="left">Alk phos<hr/></td><td align="center">94 units/L<hr/></td></tr><tr><td align="left">AST<hr/></td><td align="center">31 units/L<hr/></td></tr><tr><td align="left">Albumin<hr/></td><td align="center">5.0 g/dL<hr/></td></tr><tr><td align="left">Total protein<hr/></td><td align="center">7.4 g/dL<hr/></td></tr><tr><td align="left">Direct bilirubin<hr/></td><td align="center">&#x0003c;0.2 mg/dL<hr/></td></tr><tr><td align="left">ALT</td><td align="center">37 units/L</td></tr></tbody></table><table-wrap-foot><fn><p>Alk Phos = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = bun urea nitrogen; HGB = hemoglobin; HCT = hematocrit; PLT = platelets; WBC = white blood cells.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Treatment</title><p>The patient received a right suboccipital craniotomy and resection of the mass. Intraoperatively, the mass was noted to have a soft tissue component with a large, calcified mass. Margins of the lesion were dissected, and circumferential exposure was completed. The mass was easily removed, and the resection cavity was copiously irrigated. Hemostasis was achieved, and dura was reapproximated before replacement of the bone flap and closure of the incision.</p><p>Postoperative imaging showed a gross total resection. Pathological staining of the specimen showed positive acid-fast bacilli (AFB) and Fite stains and necrotizing granulomatous inflammation, confirming the diagnosis of a tuberculoma (<xref rid="f3" ref-type="fig">Fig. 3</xref>).</p><fig position="float" id="f3"><label>FIG. 3.</label><caption><p><bold>A:</bold> Microscopically, hematoxylin and eosin stain of the lesion revealed areas of central necrosis surrounded by epithelioid cells and inflammatory cells (magnification &#x000d7;100). <bold>B:</bold> Other areas show multinucleated giant cells, epithelioid cells, and inflammatory cells consistent with necrotizing granuloma (magnification &#x000d7;200). Staining for AFB (<bold>C,</bold> magnification &#x000d7;1,000) and FITE (<bold>D,</bold> magnification &#x000d7;1,000) are positive for acid-fast mycobacteria (<italic toggle="yes">black circles</italic>).</p></caption><graphic xlink:href="CASE21170f3" position="float"/></fig></sec><sec><title>Discharge</title><p>The patient was discharged home on postoperative day 3 on multidrug treatment for TB, including rifampin, isoniazid, ethambutol, and pyrazinamide for 2 months followed by rifampin and isoniazid for an additional 10 months, all of which required direct observational therapy per state health department policy. At discharge, the patient was awake and alert and oriented to self, place, and time with a Glasgow Coma Scale score of 15. His preoperative reports of headaches had completely resolved after surgery.</p></sec></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><sec><title>Observations</title><p>CNS TB remains a concern for patients with prior exposure to <italic toggle="yes">Mycobacterium tuberculosis</italic>, both recent and remote. Additionally, patients on active TB treatment have presented with paradoxical CNS tuberculomas, despite decreasing disease burden in the lungs.<sup><xref rid="b10" ref-type="bibr">10</xref>,<xref rid="b15" ref-type="bibr">15</xref>,<xref rid="b16" ref-type="bibr">16</xref></sup> Presenting symptoms for these caseating granulomas may vary but in general mimic those of other space-occupying intracranial lesions because they are generally secondary to the mass effect, edema, and subsequent increased intracranial pressure. These symptoms include papilledema, headache, nausea, ataxia, diplopia, and, if active TB is present, weight loss.<sup><xref rid="b1" ref-type="bibr">1</xref>,<xref rid="b4" ref-type="bibr">4</xref>,<xref rid="b6" ref-type="bibr">6</xref>,<xref rid="b17" ref-type="bibr">17</xref>,<xref rid="b18" ref-type="bibr">18</xref></sup> When present in the cerebellum, these lesions carry a greater risk of obstructive hydrocephalus due to the decreased volume of the posterior fossa and proximity to the fourth ventricle and cerebral aqueduct.</p><p>Treatment options for intracranial tuberculomas remain limited and consist primarily of a four-medication anti-TB regimen of isoniazid, rifampin, ethambutol, and pyrazinamide (RIPE) with or without corticosteroids to treat the associated cerebral edema.<sup><xref rid="b9" ref-type="bibr">9</xref>,<xref rid="b10" ref-type="bibr">10</xref></sup> Here we present a case showing efficacy of the adjunct use of resection of a solitary cerebellar tuberculoma without active or latent TB infection, leading to the cessation of symptoms and removal of the primary lesion. Resection of these lesions has been previously reported,<sup><xref rid="b2" ref-type="bibr">2</xref>,<xref rid="b8" ref-type="bibr">8</xref>,<xref rid="b15" ref-type="bibr">15</xref></sup> particularly in lesions causing significant CNS symptoms and obstructive hydrocephalus or strongly mimicking other pathologies. Lesions present in the cerebellum may be more commonly resected because they are more likely to cause these severe symptoms.<sup><xref rid="b3" ref-type="bibr">3</xref>,<xref rid="b15" ref-type="bibr">15</xref>,<xref rid="b16" ref-type="bibr">16</xref></sup> Care must be taken during surgery to minimize the spread of the infectious <italic toggle="yes">Mycobacteria</italic> because it may cause significant complications, in particular, TB meningitis. It is important to note that clinical decisions vary based on clinical picture, test results, and suspicion of CNS TB. The combination of negative serologies, no active disease, and a negative QuantiFERON test result led to the decision not to perform additional invasive testing, such as lumbar puncture and CSF analysis. Had the QuantiFERON or CT imaging showed positive results, the clinical decision to pursue further testing to confirm the diagnosis would have been favored. If this diagnosis had been confirmed by QuantiFERON or additional testing, we anticipate primary treatment would be the RIPE protocol.<sup><xref rid="b1" ref-type="bibr">1</xref>,<xref rid="b8" ref-type="bibr">8</xref>,<xref rid="b10" ref-type="bibr">10</xref></sup> Had the patient then failed RIPE or had symptoms progressed, surgical treatment would have been considered. In cases of unconfirmed CNS TB, CSF analysis can yield valuable information, including <italic toggle="yes">Mycobacterium</italic> presence by AFB staining, a mononuclear pleocytosis, high protein, low glucose, and a &#x0201c;ground-glass&#x0201d; appearance.<sup><xref rid="b10" ref-type="bibr">10</xref></sup> Given a questionable diagnosis and a CSF analysis meeting these criteria, CNS TB can be confirmed.<sup><xref rid="b10" ref-type="bibr">10</xref></sup> CSF culture may also confirm the diagnosis but may delay treatment because growth requires 3 to 6 weeks.<sup><xref rid="b10" ref-type="bibr">10</xref></sup> Additionally, the use of nucleic acid-based amplification technique (NAAT) is unclear, with the reliability of testing not established and a high rate of false-positive results.<sup><xref rid="b10" ref-type="bibr">10</xref></sup> Given a high clinical suspicion of CNS TB in combination with negative AFB staining of the CSF, NAAT may be warranted, although a negative test result does not exclude the diagnosis.<sup><xref rid="b10" ref-type="bibr">10</xref></sup></p><p>Of note, this patient was not immunosuppressed, had negative QuantiFERON test results, and did not have active pulmonary TB, all of which are commonly associated with the presentation of CNS tuberculomas. Presentation of a patient with a CNS TB infection prompts concurrent testing for immunosuppressive diseases because there have been reported cases of human immunodeficiency virus diagnosed secondary to CNS TB.<sup><xref rid="b19" ref-type="bibr">19</xref></sup> Rarely, these cases can present in patients without immunosuppression.<sup><xref rid="b20" ref-type="bibr">20</xref></sup> This case serves as a reminder that the differential diagnosis in patients with known prior TB exposure who present with an intracranial mass suspicious for infection should include CNS tuberculoma, regardless of time since exposure, presence or absence of active disease, results of QuantiFERON testing, and current immune state.</p></sec><sec><title>Lessons</title><p>We described a patient with a rare cerebellar tuberculoma without the presence of active disease. These CNS tuberculomas are an important differential to consider in patients with a history of primary TB, regardless of disease status. Resection of these lesions remains a viable treatment option that is safe and effective in conjunction with established anti-TB drug therapies.</p></sec></sec><sec id="s4"><title>Acknowledgments</title><p>We would like to thank St. George&#x02019;s University School of Medicine for their support of this research.</p></sec><sec id="s5"><title>Disclosures</title><p>The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.</p></sec><sec id="s6"><title>Author Contributions</title><p>Conception and design: St. Clair, Feinberg Acquisition of data: Capone, St. Clair, Sadr, Feinberg Analysis and interpretation of data: Capone, Emechebe Drafting the article: Capone Critically revising the article: Capone, Emechebe, Feinberg Reviewed submitted version of manuscript: Capone, Feinberg Approved the final version of the manuscript on behalf of all authors: Capone Administrative/technical/material support: St. Clair Study supervision: St. Clair, Sadr.</p></sec></body><back><ref-list><title>References</title><ref id="b1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chin</surname><given-names>JH</given-names></name></person-group><article-title>Neurotuberculosis: a clinical review</article-title><source>Semin Neurol</source><year>2019</year><volume>39</volume><issue>4</issue><fpage>456</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">31533186</pub-id></mixed-citation></ref><ref id="b2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ranjan</surname><given-names>M</given-names></name><name><surname>Saritha</surname><given-names>A</given-names></name><name><surname>Mahadevan</surname><given-names>A</given-names></name><name><surname>Shankar</surname><given-names>SK</given-names></name><name><surname>Sampath</surname><given-names>S</given-names></name></person-group><article-title>Cerebellar tuberculoma presenting as haematoma: a case report and pathophysiological consideration</article-title><source>Br J Neurosurg</source><year>2009</year><volume>23</volume><issue>2</issue><fpage>203</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">19306180</pub-id></mixed-citation></ref><ref id="b3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Binesh</surname><given-names>F</given-names></name><name><surname>Taghipour Zahir</surname><given-names>S</given-names></name><name><surname>Roshan Bovanlu</surname><given-names>T</given-names></name></person-group><article-title>Isolated cerebellar tuberculoma mimicking posterior cranial fossa tumour</article-title><source>Case Reports</source><year>2013</year><volume>2013</volume><fpage>bcr2013009965</fpage></mixed-citation></ref><ref id="b4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Greschus</surname><given-names>S</given-names></name><name><surname>Kuchelmeister</surname><given-names>K</given-names></name><name><surname>Oeynhausen</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>HP</given-names></name><name><surname>Urbach</surname><given-names>H</given-names></name></person-group><article-title>Cerebral tuberculoma mimicking brain tumor</article-title><source>Clin Neuroradiol</source><year>2014</year><volume>24</volume><issue>4</issue><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">24002352</pub-id></mixed-citation></ref><ref id="b5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Meegada</surname><given-names>S</given-names></name><name><surname>Gyamfi</surname><given-names>R</given-names></name><name><surname>Muppidi</surname><given-names>V</given-names></name><name><surname>Dandu</surname><given-names>V</given-names></name><name><surname>Challa</surname><given-names>T</given-names></name></person-group><article-title>Multiple intracranial tuberculomas with an intra-medullary spinal cord tuberculoma in a pediatric patient</article-title><source>Cureus</source><year>2020</year><volume>12</volume><issue>3</issue><fpage>e7248</fpage><pub-id pub-id-type="pmid">32292663</pub-id></mixed-citation></ref><ref id="b6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Monteiro</surname><given-names>R</given-names></name><name><surname>Carneiro</surname><given-names>JC</given-names></name><name><surname>Costa</surname><given-names>C</given-names></name><name><surname>Duarte</surname><given-names>R</given-names></name></person-group><article-title>Cerebral tuberculomas: a clinical challenge</article-title><source>Respir Med Case Rep</source><year>2013</year><volume>9</volume><issue>1</issue><fpage>34</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">26029627</pub-id></mixed-citation></ref><ref id="b7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mart&#x000ed;nez-V&#x000e1;zquez</surname><given-names>C</given-names></name><name><surname>Bord&#x000f3;n</surname><given-names>J</given-names></name><name><surname>Rodr&#x000ed;guez-Gonz&#x000e1;lez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cerebral tuberculoma: a comparative study in patients with and without HIV infection</article-title><source>Infection</source><year>1995</year><volume>23</volume><issue>3</issue><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">7499003</pub-id></mixed-citation></ref><ref id="b8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zahrou</surname><given-names>F</given-names></name><name><surname>Elallouchi</surname><given-names>Y</given-names></name><name><surname>Ghannane</surname><given-names>H</given-names></name><name><surname>Benali</surname><given-names>SA</given-names></name><name><surname>Aniba</surname><given-names>K</given-names></name></person-group><article-title>Diagnosis and management of intracranial tuberculomas: about 2 cases and a review of the literature</article-title><source>Pan Afr Med J</source><year>2019</year><volume>34</volume><fpage>23</fpage><pub-id pub-id-type="pmid">31762892</pub-id></mixed-citation></ref><ref id="b9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moussa</surname><given-names>AA</given-names></name><name><surname>Mahmoud</surname><given-names>ME</given-names></name><name><surname>Yousef</surname><given-names>HA</given-names></name></person-group><article-title>Intracranial tuberculoma and recent advances in magnetic resonance imaging</article-title><source>Egypt J Neurosurg</source><year>2018</year><volume>33</volume><issue>1</issue><fpage>13</fpage></mixed-citation></ref><ref id="b10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leonard</surname><given-names>JM</given-names></name></person-group><article-title>Central nervous system tuberculosis</article-title><source>Microbiol Spectr</source><year>2017</year><volume>5</volume><issue>2</issue><fpage>117278</fpage></mixed-citation></ref><ref id="b11"><label>11</label><mixed-citation publication-type="webpage">
<collab>Centers for Disease Control and Prevention</collab><article-title>Division of Tuberculosis Elimination</article-title><comment>TB Incidence in the United States, 1953-2019. Accessed June 19, 2021. <ext-link xlink:href="https://www.cdc.gov/tb/statistics/tbcases.htm" ext-link-type="uri">https://www.cdc.gov/tb/statistics/tbcases.htm</ext-link></comment></mixed-citation></ref><ref id="b12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Langer</surname><given-names>AJ</given-names></name><name><surname>Navin</surname><given-names>TR</given-names></name><name><surname>Winston</surname><given-names>CA</given-names></name><name><surname>LoBue</surname><given-names>P</given-names></name></person-group><article-title>Epidemiology of tuberculosis in the United States</article-title><source>Clin Chest Med</source><year>2019</year><volume>40</volume><issue>4</issue><fpage>693</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">31731978</pub-id></mixed-citation></ref><ref id="b13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sester</surname><given-names>M</given-names></name><name><surname>Sotgiu</surname><given-names>G</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><etal/></person-group><article-title>Interferon-&#x003b3; release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis</article-title><source>Eur Respir J</source><year>2011</year><volume>37</volume><issue>1</issue><fpage>100</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">20847080</pub-id></mixed-citation></ref><ref id="b14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Metcalfe</surname><given-names>JZ</given-names></name><name><surname>Everett</surname><given-names>CK</given-names></name><name><surname>Steingart</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Interferon-&#x003b3; release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis</article-title><source>J Infect Dis</source><year>2011</year><volume>204</volume><issue>suppl 4</issue><fpage>S1120</fpage><lpage>S1129</lpage><pub-id pub-id-type="pmid">21996694</pub-id></mixed-citation></ref><ref id="b15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ninomiya</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Ishida</surname><given-names>T</given-names></name><etal/></person-group><article-title>A surgical case of cerebellar tuberculoma caused by a paradoxical reaction while on therapy for tuberculosis spondylitis</article-title><source>Surg Neurol Int</source><year>2019</year><volume>10</volume><issue>162</issue><fpage>162</fpage><pub-id pub-id-type="pmid">31528497</pub-id></mixed-citation></ref><ref id="b16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Kakani</surname><given-names>A</given-names></name><name><surname>Mahajan</surname><given-names>SN</given-names></name><name><surname>Vagha</surname><given-names>SJ</given-names></name><name><surname>Acharya</surname><given-names>S</given-names></name></person-group><article-title>Paradoxical manifestation of cerebellar tuberculoma</article-title><source>Infect Dis Clin Pract</source><year>2011</year><volume>19</volume><issue>1</issue><fpage>72</fpage><lpage>74</lpage></mixed-citation></ref><ref id="b17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Togha</surname><given-names>M</given-names></name><name><surname>Sahraian</surname><given-names>MA</given-names></name><name><surname>Hosseini</surname><given-names>SJ</given-names></name><name><surname>Haddadi</surname><given-names>A</given-names></name></person-group><article-title>Brain tuberculoma: report of a case presented with prolonged nonspecific symptoms and multiple brain tuberculoma</article-title><source>Iran J Neurol</source><year>2012</year><volume>11</volume><issue>1</issue><fpage>34</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">24250858</pub-id></mixed-citation></ref><ref id="b18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>J</given-names></name><name><surname>Kinirons</surname><given-names>M</given-names></name></person-group><article-title>Intracranial tuberculomas</article-title><source>Lancet</source><year>2003</year><volume>362</volume><issue>9386</issue><fpage>797</fpage><pub-id pub-id-type="pmid">13678874</pub-id></mixed-citation></ref><ref id="b19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Meltzer</surname><given-names>E</given-names></name><name><surname>Moussawi</surname><given-names>K</given-names></name></person-group><article-title>Intracranial tuberculoma in a patient with untreated human immunodeficiency virus</article-title><source>JAMA Neurol</source><year>2017</year><volume>74</volume><issue>3</issue><fpage>356</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">28135346</pub-id></mixed-citation></ref><ref id="b20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Aikawa</surname><given-names>H</given-names></name><name><surname>Narita</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intracranial tuberculoma in non-immunosuppressive state</article-title><source>Neurol Med Chir (Tokyo)</source><year>2013</year><volume>53</volume><issue>4</issue><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">23615420</pub-id></mixed-citation></ref></ref-list></back></article>
